| Reaction Details |
|---|
 | Report a problem with these data |
| Target | D(4) dopamine receptor |
|---|
| Ligand | BDBM50145071 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | ChEMBL_60675 (CHEMBL674046) |
|---|
| Ki | 376±n/a nM |
|---|
| Citation |  Stewart, AO; Cowart, MD; Moreland, RB; Latshaw, SP; Matulenko, MA; Bhatia, PA; Wang, X; Daanen, JF; Nelson, SL; Terranova, MA; Namovic, MT; Donnelly-Roberts, DL; Miller, LN; Nakane, M; Sullivan, JP; Brioni, JD Dopamine D4 ligands and models of receptor activation: 2-(4-pyridin-2-ylpiperazin-1-ylmethyl)-1H-benzimidazole and related heteroarylmethylarylpiperazines exhibit a substituent effect responsible for additional efficacy tuning. J Med Chem47:2348-55 (2004) [PubMed] Article |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| D(4) dopamine receptor |
|---|
| Name: | D(4) dopamine receptor |
|---|
| Synonyms: | D(2C) dopamine receptor | DOPAMINE D4 | DOPAMINE D4.2 | DOPAMINE D4.4 | DRD4 | DRD4_HUMAN | Dopamine D4 receptor |
|---|
| Type: | Enzyme |
|---|
| Mol. Mass.: | 48373.19 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | P21917 |
|---|
| Residue: | 419 |
|---|
| Sequence: | MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVA
TERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCT
ASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGR
DPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSG
PGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPG
LPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWT
PFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC
|
|
|
|---|
| BDBM50145071 |
|---|
| n/a |
|---|
| Name | BDBM50145071 |
|---|
| Synonyms: | 2-(4-Pyridin-3-yl-piperazin-1-ylmethyl)-1H-benzoimidazole | CHEMBL76653 |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C17H19N5 |
|---|
| Mol. Mass. | 293.3663 |
|---|
| SMILES | C(N1CCN(CC1)c1cccnc1)c1nc2ccccc2[nH]1 |
|---|
| Structure | 
|
|---|
Search and Browse
